AKTS
Aktis Oncology, Inc. Common stock
NASDAQ: AKTS · HEALTHCARE · BIOTECHNOLOGY
$18.75
+0.16% today
Updated 2026-04-30
Market cap
$1.18B
P/E ratio
—
P/S ratio
180.88x
EPS (TTM)
$-1.21
Dividend yield
—
52W range
$15 – $29
Volume
0.4M
Aktis Oncology, Inc. Common stock (AKTS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $254834.00 | $16964.00 | $1.21M | $1.44M | $1.79M | $15.35M | $0.00 | $27.12M | $1.49M | $6.50M |
| Revenue growth (YoY) | — | — | -93.3% | +7020.2% | +19.5% | +24.0% | +757.5% | -100.0% | — | -94.5% | +336.9% |
| Cost of revenue | — | $28749.00 | $110084.00 | $1.02M | $1.01M | $2.41M | $19.49M | — | $30.24M | $28.07M | — |
| Gross profit | — | $226085.00 | $-93120.00 | $188375.00 | $430000.00 | $-624000.00 | $-4.14M | — | $-3.12M | $1.49M | $6.50M |
| Gross margin | — | 88.7% | -548.9% | 15.6% | 29.8% | -34.9% | -27.0% | — | -11.5% | 100.0% | 100.0% |
| R&D | $470987.00 | $1.76M | $4.43M | $13.27M | $19.25M | $20.52M | $35.71M | $14.30M | $25.92M | $40.95M | $67.45M |
| SG&A | $920031.00 | $2.94M | $6.02M | $8.80M | $8.70M | $10.89M | $20.71M | $5.11M | $7.68M | $11.31M | $12.60M |
| Operating income | $-1.39M | $-4.69M | $-9.96M | $-22.28M | $-27.52M | $-32.04M | $-60.55M | $-19.76M | $-34.79M | $-52.05M | $-74.68M |
| Operating margin | — | -1842.0% | -58704.1% | -1844.4% | -1906.9% | -1789.8% | -394.5% | — | -128.3% | -3500.3% | -1149.5% |
| EBITDA | $-629596.00 | $-3.87M | $-10.57M | $-20.62M | $-25.07M | $-28.96M | $-52.83M | $-19.32M | $-33.60M | $-50.48M | $-72.36M |
| EBITDA margin | — | -1518.6% | -62329.0% | -1707.1% | -1737.4% | -1617.8% | -344.1% | — | -123.9% | -3394.4% | -1113.7% |
| EBIT | $-639236.00 | $-3.90M | $-10.68M | $-21.88M | $-27.57M | $-32.15M | $-60.95M | $-19.76M | $-34.79M | $-52.05M | $-74.68M |
| Interest expense | — | — | — | $329422.00 | $2.89M | $4.57M | $77000.00 | — | $2.32M | $2.66M | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.22M | $-5.41M | $-9.11M | $-21.74M | $-30.88M | $-40.87M | $-59.19M | $-17.93M | $-28.64M | $-43.98M | $-63.73M |
| Net income growth (YoY) | — | -342.5% | -68.5% | -138.7% | -42.0% | -32.3% | -44.8% | +69.7% | -59.7% | -53.6% | -44.9% |
| Profit margin | — | -2121.4% | -53691.6% | -1799.8% | -2139.9% | -2283.1% | -385.6% | — | -105.6% | -2957.6% | -980.9% |